The pharmaceutical industry has immense pressure to deliver advanced and novel therapies to patients worldwide but faces monumental challenges in drug development. On average, the journey from ...

A living evidence approach treats evidence as shared infrastructure rather than as a series of isolated projects.

I examine the applicability of relative R&D spending as a potential leading indicator of shareholder returns. In addition, the correlation of R&D spending with stock volatility and sales growth is ...

Pharma’s return on investment (ROI) for research and development (R&D) is seeing a comeback after a record low in 2022, according to a recent report out of Deloitte. ROI on pharma R&D jumped to 4.1% ...

This investment coincides with China’s burgeoning presence in the pharmaceutical industry, driven by an uptick in innovative medicines R&D.

In 2023, Johnson & Johnson announced it had stopped research and development on therapeutics for many infectious diseases, including hepatitis and tuberculosis. Less visibly, AbbVie shuttered last ...

Circle Pharma, a clinical-stage biopharmaceutical company dedicated to discovering and developing cell-permeable macrocycles as a new class of therapies, today announced the successful closing of a ...

With Democrats taking control of the White House and Senate and much government money still to be allocated to remedy the coronavirus pandemic, the pharmaceutical industry has ramped up its efforts to ...

SALZBURG, Austria--(BUSINESS WIRE)--After successfully launching the D-mine ® Pump, an infusion device designed to provide precise continuous subcutaneous drug delivery for Parkinson´s patients, EVER ...

LONDON (Reuters) - At just 28, Duncan Casey has already been from the university science bench to the world of Big Pharma research and back again. Now working in an Imperial College lab tucked behind ...

SALZBURG, Austria--(BUSINESS WIRE)--After successfully launching the D-mine ® Pump, an infusion device designed to provide precise continuous subcutaneous drug delivery for Parkinson´s patients, EVER ...